These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 21428128

  • 1. Next generation anticoagulants may push warfarin to the wayside.
    Kirsch B.
    Manag Care; 2011 Feb; 20(2):33-6. PubMed ID: 21428128
    [No Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV, Gage BF.
    Circulation; 2011 Jun 07; 123(22):2562-70. PubMed ID: 21606397
    [Abstract] [Full Text] [Related]

  • 3. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug 07; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 4. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ.
    Circulation; 2011 Jan 18; 123(2):131-6. PubMed ID: 21200007
    [Abstract] [Full Text] [Related]

  • 5. Place of dabigatran in contemporary pharmacotherapy.
    Gums JG.
    Pharmacotherapy; 2011 Apr 18; 31(4):335-7. PubMed ID: 21449622
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dabigatran: will it change clinical practice?
    Wartak SA, Bartholomew JR.
    Cleve Clin J Med; 2011 Oct 18; 78(10):657-64. PubMed ID: 21968472
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services.
    Atay JK, Fanikos J, Barnes GD, Ehle M, Coatney J, Piazza G, Froehlich JB, Goldhaber SZ.
    Am J Cardiol; 2013 Aug 01; 112(3):387-9. PubMed ID: 23647794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atrial fibrillation in 2010: advances in treatment and management.
    Connolly SJ.
    Nat Rev Cardiol; 2011 Feb 01; 8(2):67-8. PubMed ID: 21270842
    [Abstract] [Full Text] [Related]

  • 16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Feb 01; 27(1):74-90. PubMed ID: 21329865
    [Abstract] [Full Text] [Related]

  • 17. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
    Belavic JM.
    Nurse Pract; 2011 Sep 01; 36(9):6-7. PubMed ID: 21857210
    [No Abstract] [Full Text] [Related]

  • 18. Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.
    Luis SA, Poon K, Luis C, Shukla A, Bett N, Hamilton-Craig C.
    Circ Cardiovasc Imaging; 2013 May 01; 6(3):491-2. PubMed ID: 23696587
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.
    Flaker G, Ezekowitz M, Yusuf S, Wallentin L, Noack H, Brueckmann M, Reilly P, Hohnloser SH, Connolly S.
    J Am Coll Cardiol; 2012 Feb 28; 59(9):854-5. PubMed ID: 22361407
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.